Primary Aldosteronism: an update on the management

35
Primary Aldosteronism: an update on the management Dr Man Chi Mei Vivian Queen Mary Hospital

description

Primary Aldosteronism: an update on the management. Dr Man Chi Mei Vivian Queen Mary Hospital. Content. Background information Diagnostic algorithms Localization and subtype differentiation Management. Case Scenario. 60/M , good past health Blood test confirmed primary aldosteronism. - PowerPoint PPT Presentation

Transcript of Primary Aldosteronism: an update on the management

Page 1: Primary Aldosteronism:  an update on the management

Primary Aldosteronism: an update on the management

Dr Man Chi Mei Vivian

Queen Mary Hospital

Page 2: Primary Aldosteronism:  an update on the management

Content

• Background information

• Diagnostic algorithms

• Localization and subtype differentiation

• Management

Page 3: Primary Aldosteronism:  an update on the management

Case Scenario

• 60/M , good past health • Blood test confirmed primary aldosteronism

7mm left adrenal nodule17mm right adrenal nodule

Page 4: Primary Aldosteronism:  an update on the management

What should be the management?

• Adrenalectomy– Right adrenalectomy?– Left adrenalectomy?– Bilateral adrenalectomy?

• Medical therapy with aldosterone receptor antagonist

Page 5: Primary Aldosteronism:  an update on the management

Background• First described in 1954

• Group of disorders in which aldosterone production is inappropriately high, relatively autonomous, and non-suppressible by sodium loading1

• Estimated prevalence of 11.2% in hypertensives2

• Hypokalemia not always present– 52% aldosterone-producing adenoma– 83.1% bilateral adrenal hyperplasia

Jerome W. Conn (1907-1994)

1 J Clin Endocrinol Metab 93:3266-3281, 20082 Rossi et al. JACC vol. 48, No. 11. 2006: 2293-300

Page 6: Primary Aldosteronism:  an update on the management

Types of Primary Aldosteronism

Types Approximate prevalence %

Aldosterone-producing adenoma 30

Bilateral idiopathic hyperaldosteronism 65

Primary adrenal hyperplasia <2

Aldosterone-producing adrenocortical carcinoma

1

Aldosterone-producing ovarian tumor <1

Familial hyperaldosteronism <2

Role for adrenal venous sampling in primary aldosteronism. Young WF et al. Surgery. December 2004.

Page 7: Primary Aldosteronism:  an update on the management

Diagnosis of primary aldosteronism

• Screening– Aldosterone/ renin ratio (ARR)– Plasma aldosterone concentration (PAC)– Elevated ARR >20ng/dl per ng/ml/h and PAC

>10ng/dL

• Confirmation– Intravenous saline load/ oral salt load– Captopril challenge test– Fludro-cortisone suppression test

Page 8: Primary Aldosteronism:  an update on the management

Lateralization and subtype differentiation

• Computed tomography (CT)

• Adrenal scintigraphy

• Adrenal venous sampling (AVS)

Page 9: Primary Aldosteronism:  an update on the management

Computed tomography

Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10

Page 10: Primary Aldosteronism:  an update on the management

Adrenocortical adenomaAdrenocortical carcinoma

Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10

Page 11: Primary Aldosteronism:  an update on the management

Lateralization and subtype differentiation

• Computed tomography (CT)

• Adrenal scintigraphy

• Adrenal vein sampling (AVS)

Page 12: Primary Aldosteronism:  an update on the management

Adrenal Scintigraphy• Provides functional information• 131I-6β-iodomethyl-19-norcholesterol (NP-59)• Marker of adreno-cortical uptake

Huang YE et al. Role of 131I-NP-59 Adrenal Imaging in Patients ofACTH-Independent Cushing’s Syndrome. Ann Nucl Med Sci 2001;14:75-83

Page 13: Primary Aldosteronism:  an update on the management

Chen YC et al. Use of NP-59 SPECT/ CT imaging in atypical primary aldosteronism. Q J Med (2013)

Page 14: Primary Aldosteronism:  an update on the management

Lateralization and subtype differentiation

• Computed tomography (CT)

• Adrenal scintigraphy

• Adrenal venous sampling (AVS)

Page 15: Primary Aldosteronism:  an update on the management

Adrenal vein sampling

• First proposed in 1967 as a test to distinguish between aldosterone-producing adenoma and idiopathic hyperaldosteronism

• Gold standard for lateralization of disease

• Femoral venous access• Simultaneously left and right adrenal venous

sampling • Blood aldosterone and cortisol level

Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125

Page 16: Primary Aldosteronism:  an update on the management

Interpretation

• Confirmation of correct position of adrenal catheters:– Cortisol level from adrenal catheters being 5-10 times

the value obtained from peripheral sheath

• Asymmetrical aldosterone: cortisol values on the affected side being 3-5 times the value obtained from the unaffected side

Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125

Page 17: Primary Aldosteronism:  an update on the management

Right adrenal vein catheterizationLeft adrenal vein catheterization

Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125

Lau JHG et al . Clinical Endocrinology (2010) 76; 182-188

Page 18: Primary Aldosteronism:  an update on the management

Diagnostic values and accuracy

• 203 patients were selected for AVS from 1990-2003

• 194 patients underwent successful adrenal vein cannulation– Success rate 95.6%

• Computed tomography, AVS and histopathological findings were compared

Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35

Page 19: Primary Aldosteronism:  an update on the management

Discordant between CT and AVS

• 110 patients (56.7%) had unilateral source for aldosterone hyper-secretion

Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35

Normal CT scan 24

Bilateral micronodule 16

Bilateral macronodule 2

Unilateral micronodule 7/31 contralateral gland

Unilateral macronodule 1/22 contralateral gland

Combination of micronodule and macronodule

11/18 macronodule

4/18 micronodule

Page 20: Primary Aldosteronism:  an update on the management

Discordant between CT and AVS• 21.7% (42 patients)

would have been incorrectly excluded as candidates for adrenalectomy

• 24.7% (48 patients) might have unnecessary or inappropriate adrenalectomy

Young WF et al. Role of adrenal venous sampling in primary aldosteronism. Surgery 2004; 136: 1227-35

Page 21: Primary Aldosteronism:  an update on the management

Discordant between CT/MRI and AVS

• Systematic review of 38 studies, 950 patients included– 37.8% discordance between CT/MRI and AVS– 14.6% inappropriate adrenalectomy – 19.1% inappropriate exclusion from

adrenalectomy– 3.9% adrenalectomy on wrong side

Kempers MJE et al. Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism. Annals of Internal Medicine, 09/2009, Volume 151, Issue 5, pp. 329 - 337

Page 22: Primary Aldosteronism:  an update on the management

Computed tomography

Adrenal venous sampling

NP-59 adrenal scintigraphy

•Easily available •Technically demanding

•expertise required

•Requirement of radio-labeled material

•3-5 day test

•Non-invasive •Invasive

•complication rate ~2.5%3

•Non-invasive

•Good resolution •Limited spatial resolution

•Improved with NP-59 SPECT/CT

•Sensitivity 77%1

•Specificity 80%1

•Accuracy improved if discrete unilateral macronodule

•Sensitivity 95%4

•Specificity 100%4

•Planar scintigraphy sensitivity as low as 40%2

•Sensitivity increased to 81.8% when combined with CT2

1. Lau JHG et al . Clinical Endocrinology (2010) 76; 182-1882. Yen RF et al. The Journal of Nuclear Medicine (2009) 50; 10: 1631-16373. Young WF et al. Surgery (2004) 136; 6; 1227-12344. Tsai YS et al. Formos J Endocrin Metab 2011; 2(2): 38-43

Page 23: Primary Aldosteronism:  an update on the management

Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125

Page 24: Primary Aldosteronism:  an update on the management

Management

• Bilateral idiopathic hyperaldosteronism– Medical treatment: aldosterone receptor antagonist– Intolerance/ refractory cases: bilateral adrenalectomy

• Aldosterone producing adenoma• Primary adrenal hyperplasia

– Adrenalectomy (laparoscopic/ open)

• Emerging therapies: – Acetic acid injection– Radiofrequency ablation

Moo TA et al. Prediction of Successful Outcome in Patients with Primary Aldosteronism. Current treatment options in oncology (2007) 8:314-321

Page 25: Primary Aldosteronism:  an update on the management

Back to our patient

• Adrenal to peripheral cortisol level:– Right side: 3.6 versus left side: 3.2

• Lateralization index 7.4– Right side: 42 versus left side: 5.7

• Right adrenalectomy performed and Conn’s adenoma confirmed• Improvement in ARR one month after operation

Page 26: Primary Aldosteronism:  an update on the management

Conclusion

• Primary aldosteronism is frequently under-diagnosed in hypertensives

• Aldosterone producing adenoma and bilateral idiopathic hyperaldosteronism are two commonest causes of primary aldosteronism

• Lateralization is important for identification of surgically-amendable causes

Page 27: Primary Aldosteronism:  an update on the management

Reference• Galati SJ et al. Primary aldosteronism: emerging trends. Trends in

Endocrinology and Metabolism. September 2013, Vol.24, No. 9• Role for adrenal venous sampling in primary aldosteronism. Young

WF et al. Surgery. December 2004.• Schwatz et al. Screening for primary aldosteronism in essential

hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clinical Chemistry. 51:2. 386-394

• Young WF et al. The incidentally discovered adrenal mass. New England Journal of Medicine 2007; 356: 601-10

• Kahn SL et al. Adrenal vein sampling. Techniques in vascular and interventional radiology 13: 110-125

• Huang YE et al. Role of 131I-NP-59 Adrenal Imaging in Patients of ACTH-Independent Cushing’s Syndrome. Ann Nucl Med Sci 2001;14:75-83

• Chen YC et al. Use of NP-59 SPECT/ CT imaging in atypical primary aldosteronism. Q J Med (2013)

Page 28: Primary Aldosteronism:  an update on the management

• Rossi GP et al. A Prospective Study of the Prevalence of Primary Aldosteronism in 1125 Hypertensive Patients. JACC vol 48, No 11, 2006

• Moo TA et al. Prediction of Successful Outcome in Patients with Primary Aldosteronism. Current treatment options in oncology (2007) 8:314-321

• Stowasser M et al. Update in Primary aldosteronism. J Clin Endocrinol Metab (2009) 94: 3623-3630

• Liu SYW et al. Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease. Annals of Surgery 256(6): 1058-1064

• Kempers MJE et al. Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism. Annals of Internal Medicine, 09/2009, Volume 151, Issue 5, pp. 329 - 337

• American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas

• The Endocrine Society’s Clinical Guidelines. J Clin Endocrinol Metab 93: 3266-3281, 2008

Page 29: Primary Aldosteronism:  an update on the management

Thank you

Questions?

Page 30: Primary Aldosteronism:  an update on the management
Page 31: Primary Aldosteronism:  an update on the management

Who should be screened?

• Moderate to severe hypertension• Resistant hypertension• Hypertension with a family history of early-onset

disease• Hypertension with an adrenal incidentaloma• History of cerebrovascular accident occurring

before age 40 years• First-degree relative with primary aldosteronism

Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9

Page 32: Primary Aldosteronism:  an update on the management

Sequelae of primary aldosteronism

Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9

Page 33: Primary Aldosteronism:  an update on the management

Protocol Interpretation

Intravenous saline load

•Infusion of 2L of 0.9% normal saline over 2 hours

•In recumbent position

PAC > 10ng/dL post-infusion is highly suggestive of PA

Oral salt load •Sodium intake >6g/day for 3 days with diet and sodium chloride tabs

24 hour urinary aldosterone excretion >12μg/day consistent with PA

Captopril challenge test

•25-50mg oral captopril after sitting or standing for 1 hour

ARR >30-50

PAC remained elevated (>8.5ng/dL or greater)

Renin remained suppressed

Fludro-cortisone suppression test

•0.1mg of fludro-cortisone every 6 hours for 4 days

PAC > 6 ng/dL confirms PA

Renin suppressed to <1ng/mL/h

Cortisol measured 10am lower than measured 7-8am

Galati SJ et al. Primary aldosteronism: emerging trends. Trends in Endocrinology and Metabolism. September 2013, Vol.24, No. 9

Page 34: Primary Aldosteronism:  an update on the management
Page 35: Primary Aldosteronism:  an update on the management

Drug therapy Drug free

Optimum ratio 95%CI 12.4 (7.1 – 16.6) 14.9 (14.2 – 20.9)

Sensitivity 95%CI 73 87

Specificity 95%CI 74 75

Schwatz et al. Screening for primary aldosteronism in essential hypertension: Diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clinical Chemistry. 51:2. 386-394